logo

For the Inventor, By the Inventor

Louisville, KY, United States of America

Adnan M Mjalli

This inventor holds 12 USPTO granted patents. Top assignees: Ontogen Corporation, Other. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adnan M Mjalli. Retrieved from https://idiyas.com/inventor/adnan-m-mjalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 144(Granted Patents)


Location History:

  • Vista, CA (US) (1997 - 1999)
  • Louisville, KY (US) (1998 - 2000)
  • Escondido, CA (US) (1998 - 2000)
  • Econdido, CA (US) (2002)

Company Filing History:

goldMedal10 out of 23 
 
Ontogen Corporation
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 1997-2002

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6388076 - Protein tyrosine phosphatase-inhibiting compounds (2002-05-14),
2. 6150532 - Modulators of proteins with phosphotyrosine recognition units (2000-11-21),
3. 6117940 - Amino-ketone solid support templates (2000-09-12),
4. 6107274 - Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase) (2000-08-22),
5. 5965558 - Modulators of proteins with phosphotyrosine recognition units (1999-10-12),
6. 5866569 - Naphthalenedione nitric oxide synthase (NOS) inhibitors (1999-02-02),
7. 5840721 - Imidazole derivatives as MDR modulators (1998-11-24),
8. 5770620 - Aryl acrylic acid derivatives useful as protein tyrosine phosphatase (1998-06-23),
9. 5756527 - Imidazole derivatives useful as modulators of multi drug resistances (1998-05-26),
10. 5753687 - Modulators of proteins with phosphotryrosine recognition units (1998-05-19),
11. 5723451 - Nitric oxide synthase (NOS) inhibitors (1998-03-03),
12. 5700826 - 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug (1997-12-23),

Title: Adnan M Mjalli: Innovator in Protein Modulation

Introduction

Adnan M Mjalli is a prominent inventor based in Louisville, KY (US). He has made significant contributions to the field of protein modulation, holding a total of 12 patents. His work focuses on developing compounds that can inhibit protein tyrosine phosphatases, which play a crucial role in various biological processes.

Latest Patents

Among his latest patents is a groundbreaking invention related to protein tyrosine phosphatase-inhibiting compounds. This invention encompasses modulators of proteins with phosphotyrosine recognition units. The compounds are designed for various applications, including the treatment of human and animal disorders, purification of proteins or glycoproteins, and diagnostic uses. The invention details the modulation of the activity of molecules with phosphotyrosine recognition units, including protein tyrosine phosphatases (PTPases) and proteins with Src-homology-2 domains, across different systems such as in vitro, microorganisms, eukaryotic cells, and whole animals.

Career Highlights

Adnan has worked with Ontogen Corporation, where he contributed to innovative research and development projects. His expertise in protein modulation has positioned him as a key figure in the field.

Collaborations

Throughout his career, Adnan has collaborated with notable professionals, including Sepehr Sarshar and Xiaodong Cao. These collaborations have further enhanced his research and development efforts.

Conclusion

Adnan M Mjalli's contributions to the field of protein modulation through his innovative patents highlight his role as a leading inventor. His work continues to impact the scientific community and offers promising avenues for future research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…